Target intelligence / Profile preview

General zinc-binding sites in proteins

Molecular classification
Structural motif, Metal-binding site, Other
01

Overview

General zinc-binding sites in proteins refer to structural motifs where a zinc ion (Zn2+) is coordinated by specific amino acid residues, most commonly cysteine, histidine, glutamate, and aspartate. These sites are ubiquitous in the human proteome, serving either catalytic roles in enzymes like carbonic anhydrases and matrix metalloproteinases or structural roles in proteins such as zinc finger transcription factors. In catalytic sites, the zinc ion often acts as a Lewis acid to activate water or a substrate for chemical reactions, while in structural sites, it stabilizes the protein's three-dimensional fold. Because approximately 10% of the human proteome consists of zinc-binding proteins, these sites are frequent targets for drug design, particularly through the use of chelating agents or zinc-binding groups. However, targeting 'general' zinc-binding sites is not a viable therapeutic strategy due to the extreme risk of non-specific toxicity; instead, drug discovery focuses on achieving selectivity for the unique environment surrounding the zinc ion in a specific protein target.

Other names
Zinc-binding motifsZinc-coordination sitesZinc fingersZinc clustersMetalloprotein zinc sites
02

Mechanism of action

Drugs typically target zinc-binding sites by utilizing a zinc-binding group (ZBG), such as a hydroxamate, carboxylate, or thiol, to coordinate with the catalytic zinc ion, thereby competitively inhibiting the enzyme's activity.

03

Biological functions

CatalysisStructural stabilityGene regulationSignal transductionProtein-protein interaction
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseInfection
05

Safety considerations

Lack of selectivityOff-target toxicity due to the ubiquity of zinc-binding proteinsSystemic zinc dyshomeostasisInterference with essential cellular processes like DNA repair and transcription
06

Interacting drugs

Vorinostat

4 more in the full profile.

07

Biomarkers

Serum zinc levelsMatrix metalloproteinase activityCarbonic anhydrase expression

Beyond the preview

Go deeper on General zinc-binding sites in proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General zinc-binding sites in proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call